Intech Biopharm Corporation

NT$26.70As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6461Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (7.71%)
Div yield —
ROE (47.57%)
Biotechnology
Beta (5Y) 0.09
PE TTM —
TSR TTM (1.40%)
Mkt cap NT$2.946B
ROIC (11.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$30
11.41%
252.79%
Hold 5|1|9|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.33
0.36
0.36
0.34
38.05%
34.81%
30.36%
16.23%
RevenueNT$M
191.9
195.0
201.8
204.7
10.46%
9.44%
7.92%
12.09%
Peers (US$88.97M)
Cap (US$)
PE
89.01M
131.4x
Capital
TTM
5Y
10Y
Leveragex
0.403
0.176
0.166
EBIT/Intx
0.599
0.239
0.230
Own earn%
(343.60)
93.80
47.49
Sh yield%
33.42
29.43
29.56
Owners
Insiders/Inst%
10.07
25.75
Short interest%
4.56
SBC / revenue%
2.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–7
$1 testx
0.3
Incr. ROIC%
11